We determined that LINC01016 promoted TNBC cell proliferation and invasion by binding to and stabilizing DHX9 protein through competitive inhibition of the E3 ubiquitin ligase RFFL, thus activated DHX9-mediated PI3K/AKT signaling to accelerate breast tumor progression. The gene discussed is DHX9; the disease is breast neoplasm.